Skip to main content
SpringerLink
Log in

Planning for the exit

  • Bioentrepreneur
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Abstract

As the biotech industry has matured, the exit process has evolved. Entrepreneurs need to build today's companies based on the new exit paradigm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Author information

Authors and Affiliations

  1. Kenneth E. Eheman Jr. is a partner at Wyrick Robbins Yates & Ponton LLP, Raleigh, North Carolina, USA.,

    Kenneth E Eheman Jr

Authors
  1. Kenneth E Eheman Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth E Eheman Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eheman, K. Planning for the exit. Nat Biotechnol 30, 132–134 (2012). https://doi.org/10.1038/nbt.2093

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2093

  • Springer Nature America, Inc.

Search

Navigation